| Date Filed | Type | Description |
| 06/12/2023 |
3
| Chudnovsky Yekaterina (Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/12/2023 |
3
| Haqq Christopher (See Remarks) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/07/2023 |
3
| DeMuth Peter (Chief Scientific Officer) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/07/2023 |
3
| Segal Assaf (Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/07/2023 |
3
| RUFFOLO ROBERT R (Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/07/2023 |
3
| Matthies Annette (Chief Business Officer) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/07/2023 |
3
| ADAMS JULIAN (Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/07/2023 |
3
| Connelly Robert (CEO, President and Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/07/2023 |
3
| Ashe Carol Gail (Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 06/05/2023 |
4
| Piekos Brian (CFO) has filed a Form 4 on Elicio Therapeutics, Inc.|
Txns:
| Granted 75,484 options to buy
@ $10, valued at
$754.8k
|
|
| 06/05/2023 |
3
| Piekos Brian (CFO) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Nissenson Allen (Director) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Bought 7,346 shares
@ $1.16, valued at
$8.5k
Bought 2,037 shares
@ $1.18, valued at
$2.4k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Bought 66,907 shares
@ $2.5486, valued at
$170.5k
Bought 210,337 shares
@ $2.6617, valued at
$559.9k
|
|
| 12/22/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Bought 3,527 shares
@ $2.5449, valued at
$9k
|
|
| 12/21/2021 |
4
| Neylan John F. (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Sold 358 shares
@ $2.6201, valued at
$938 |
|
| 12/20/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Bought 27,883 shares
@ $2.5461, valued at
$71k
Bought 13,742 shares
@ $2.5439, valued at
$35k
|
|
| 12/17/2021 |
4
| Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Paid exercise price by delivering 41,091 shares
@ $13.78, valued at
$566.2k
Bought 77,604 shares
@ $2.4091, valued at
$187k
|
|
| 12/16/2021 |
4
| CURHAN GREGORY S (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Bought 4,000 shares
@ $2.37, valued at
$9.5k
|
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Goldberg Itzhak (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Sold 32,118 shares
@ $3.3539, valued at
$107.7k
|
|
| 12/03/2021 |
4
| Goldberg Itzhak (See Remarks) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Sold 38,867 shares
@ $3.542, valued at
$137.7k
Sold 38,800 shares
@ $3.5136, valued at
$136.3k
Sold 40,215 shares
@ $3.3872, valued at
$136.2k
|
|
|